Ábel Decmann1, Pál Perge1, Miklós Tóth1, Peter Igaz2,3. 1. 2nd Department of Medicine, Semmelweis University, Szentkirályi str. 46., Budapest, 1088, Hungary. 2. 2nd Department of Medicine, Semmelweis University, Szentkirályi str. 46., Budapest, 1088, Hungary. igaz.peter@med.semmelweis-univ.hu. 3. MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Szentkirályi str. 46., Budapest, 1088, Hungary. igaz.peter@med.semmelweis-univ.hu.
Abstract
INTRODUCTION: Adrenal myelolipoma is an invariably benign neoplasm of the adrenal gland that is the second most common primary adrenal incidentaloma following adrenocortical adenomas. It is composed of elements of adipose tissue and extramedullary hematopoiesis. Hypotheses on stem cells and hormonal factors have been formulated regarding its pathogenesis that is still obscure. Despite its benign behavior, adrenal myelolipoma is clinically relevant as it might cause significant difficulties in the differential diagnosis of adrenal tumors. METHODS: We have reviewed 420 cases reported between 1957 and 2017 on adrenal myelolipoma retrieved from PubMed and Scopus databases and also 20 of our case series to provide a comprehensive analysis of their pathology, epidemiological and clinical features. RESULTS AND CONCLUSIONS: The average age for its diagnosis was 51 years, and no gender difference was observed. The average size of tumors was 10.2 cm. Congenital adrenal hyperplasia was associated to 10% of all cases analyzed, while other adrenal hypersecretory disorders (cortisol, aldosterone) were found in 7.5% of cases. Computed tomography and magnetic resonance imaging can be reliably used for its differential diagnosis. If the diagnosis of an adrenal myelolipoma is unambiguous, and no associated symptoms or hormonal activity are established, surgical intervention is usually not necessary.
INTRODUCTION:Adrenal myelolipoma is an invariably benign neoplasm of the adrenal gland that is the second most common primary adrenal incidentaloma following adrenocortical adenomas. It is composed of elements of adipose tissue and extramedullary hematopoiesis. Hypotheses on stem cells and hormonal factors have been formulated regarding its pathogenesis that is still obscure. Despite its benign behavior, adrenal myelolipoma is clinically relevant as it might cause significant difficulties in the differential diagnosis of adrenal tumors. METHODS: We have reviewed 420 cases reported between 1957 and 2017 on adrenal myelolipoma retrieved from PubMed and Scopus databases and also 20 of our case series to provide a comprehensive analysis of their pathology, epidemiological and clinical features. RESULTS AND CONCLUSIONS: The average age for its diagnosis was 51 years, and no gender difference was observed. The average size of tumors was 10.2 cm. Congenital adrenal hyperplasia was associated to 10% of all cases analyzed, while other adrenal hypersecretory disorders (cortisol, aldosterone) were found in 7.5% of cases. Computed tomography and magnetic resonance imaging can be reliably used for its differential diagnosis. If the diagnosis of an adrenal myelolipoma is unambiguous, and no associated symptoms or hormonal activity are established, surgical intervention is usually not necessary.
Authors: Elena Bishop; John N Eble; Liang Cheng; Mingsheng Wang; Donald R Chase; Attilio Orazi; Dennis P O'Malley Journal: Am J Surg Pathol Date: 2006-07 Impact factor: 6.394
Authors: Shakil H Merchant; Christopher M Herman; Mitual B Amin; Jae Y Ro; Patricia Troncoso Journal: Arch Pathol Lab Med Date: 2002-06 Impact factor: 5.534
Authors: William D Craig; Julie C Fanburg-Smith; Leonard R Henry; Rubén Guerrero; Joel H Barton Journal: Radiographics Date: 2009 Jan-Feb Impact factor: 5.333
Authors: Rabea A Gadelkareem; Ahmed M Moeen; Mahmoud Khalil; Ahmed Reda; Mahmoud Farouk; Islam F Abdelkawi; Rania Makboul; Nasreldin Mohammed; Dia A Hameed Journal: Curr Urol Date: 2020-06-23
Authors: Poh Shean Wong; Lit Sin Yong; Nor Afidah Binti Karim; Ee Leng Gan; See Guan Toh; Noor Lita Binti Adam Journal: J ASEAN Fed Endocr Soc Date: 2021-04-17